Gene expression profiling of p53+/- knockout and wild-type mice following diethylstilbestrol administration

IUBMB Life

Volumn 56, Issue 7, 2004, Pages 409-416

  Salleh, Mohd Nazil ^a   Ismail, Patimah ^a   Abdullah, Abdul Salam ^b   Taufiq Yap, Yun Hin ^b   Carmichael, Paul ^c  

^a UPM   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Diethylstilbestrol (DES); Gene expression; p53+ transgenic mice

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CLASTOGEN; DIETHYLSTILBESTROL; DRUG VEHICLE; FAS LIGAND; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYC PROTEIN; NUCLEAR FACTOR KAPPA B1; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL X; PROTEIN E124; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CYCLE; CONTROLLED STUDY; DENSITOMETRY; DISEASE MODEL; DNA FINGERPRINTING; DNA MICROARRAY; GAPDH GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ASSOCIATION; HORMONE ACTION; KIDNEY PARENCHYMA; KNOCKOUT MOUSE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE DIAGNOSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRAIN IDENTIFICATION; TRANSCRIPTION REGULATION; UTERUS; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CARCINOGENS; CELL CYCLE; DENSITOMETRY; DIETHYLSTILBESTROL; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KIDNEY; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UTERUS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 9444245840     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540400003425     Document Type: Article

References (26)

1. Noller, K. L., and Fish, C. K. (1974) Diethylstilbestrol usage; its interesting past, important present and questionable future. Med. Clin. North. Am. 58, 739-810.
2. Herbst, A. L., Ulfelder, H., and Poskanzer, D. C. (1971) Adenocarcinoma of the vagina association of maternal stilbestrol therapy with tumour appearance in young women. N. Engl. J. Med. 284, 878-881.
3. Marselos, M., and Tomatis, L. (1993) Diethylstilbestrol II: Pharmacology, toxicology and carcinogenicity in humans. Eur. J. Cancer 29, 1182-1189.
4. Gass, G. H., Coats, D., and Graham, N. (1964) Carcinogenic dose-response curve to oral diethylstilbestrol. J. Natl. Cancer Inst. 33, 971-977.
5. Robinson, D. (1998) The International Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol. Pathol. 26, 474-475.
6. Moorthy, B., Liehr, J., Randerath, E., and Randerath, K. (1995) Evidence form P-postlabeling and the use of pentachlorophenol for a novel metabolic activation pathway of diethylstilbestrol and its dimethylether in mouse liver likely alpha-hydroxylation of ethyl group(s) followed by sulfate conjugation. Carcinogenesis 16, 2643-2648.
7. French, J. E., Splanding, J. W., and Dunnick, J. K. (1999) The use of transgenic animals in cancer testing. Inhal. Toxicol. 11, 541-544.
8. Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., and Donehower, L. A. (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5, 225-229.
9. Tennant, R. W., Stasiewicz, S., Mennear, J., French, J. E., and Spalding, J. W. (1999) Genetically altered mouse models for identifying carcinogens. IARC Sci. Publ. 146, 123-150.
10. Gulezian, D., Jacobson-Kram, D., McCullough, C. B., Olson, H., Recio, L., Robinson, D., Storer, R., Tennant, R., Ward, J. M., and Neumann, D. A. (2000) Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment. Toxicol. Pathol. 26, 482-499.
11. +/- hemizygous knockout mice: studies with diethylstilbestrol. Toxicol. Pathol. 29, 155-160.
12. +/- knockout mice using focused arrays. Toxicology 185(1-2), 49-57.
13. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. (2003) Thymoctye apoptosis induced by p53-dependent and p53-independent pathway. Nature 362, 849-852.
14. Bouvard, V., Zaitchouk, T., Vacher, M., et al. (2000) Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene 19, 649-660.
15. Boley, S. E., Wong, V. A., French, J. E., and Recio, L. (2002) p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene. Toxicol. Sciences 66, 209-215.
16. Barak, Y., Juven, T., Haffner, R., and Oren, M. (1993) mdm2 expression is induced by wild type p53 activity. EMBO J. 12(2), 461-468.
17. Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D., and Levine, A. J. (1993) The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 90, 11623-11627.
18. Lane, D. P., and Hall, P. A (1997) MDM2-arbiter of p53's destruction. Trends Biochem. Sci., 22, 372-374.
19. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. J. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597.
20. Clarke, A., Purdie, C., Harrison, et al. (1993) Thymocyte apoptosis induced by p53-dependent and p53-independent pathway. Nature 362, 849-852.
21. Reed, J. C. (1994) Bcl-2 and the regulation of programmed cell death. Cell Biol. J. 124, 1-6.
22. Kang, Y., Cortina, R., and Perry, R. (1996) Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J. Natl Cancer Inst. 88, 279-284.
23. Altucci, L., Addeo, R., Cicatiello, L., Germano, D., Pacilio, C., et al. (1997) Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5 and 6 and increases cyclin messenger. Endocrinology 138, 978-984.
24. Suzuki, A., Matsuzawa, A., and Lguchi, T. (1996) Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene 13, 31-37.
25. Turley, J. M., Fu, T., Ruseetti, F. W., Mikovits, J. A., Bertolette, D. C., and Birchenall-Roberts, M. C. (1997) Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res. 57, 881-890.
26. Kroemer, G., and Reed, J. C. (2000) Mitochondrial control of cell death. Nature Medicine 6, 513-519.